Biomedical and Entrepreneurship Training for Aging (BETA)

到2050年，美国65岁以上人口的比例预计将达到22%。医疗保健创新在改善老年人的健康和福祉方面发挥了至关重要的作用。然而，学术界和产业界之间仍然存在一个重大差距，必须弥合这一差距，以推动新药、设备和技术的创新和商业化，以对抗与年龄有关的疾病，包括阿尔茨海默病（AD）和阿尔茨海默病相关痴呆（ADRD）。在与年龄有关的疾病方面接受高级培训的研究生和博士后学员构成了能够填补这一空白的重要劳动力；然而，目前的培训计划并没有提供必要的业务和沟通技巧，以使这些受训者能够填补这一空白。该申请的总体目标是通过创建针对老龄化的生物医学创业培训（BETA）计划来培养促进健康老龄化的科学工作人员。密歇根大学非常适合作为一个教育项目的中心，专注于在老龄化相关学科中从事职业的研究生和博士后，因为它在一个校区内设有医学院、工程学院、卫生专业学院、护理学院、新闻学院和综合的密歇根大学卫生系统。MU拥有支持创业教育的优秀项目，包括生命科学创新与创业研究生项目、中西部生物医学加速器联盟、美国国立卫生研究院资助的研究评估和商业化中心（REACH）、库尔特生物医学加速器和MU生命科学商业孵化器。密苏里大学系统拥有近70万名学生和数百个研究生项目，为BETA学员提供了一个强大的来源，包括密苏里大学跨学科神经科学研究生培训项目、密苏里大学堪萨斯城分校（UMKC）应用认知与脑科学博士项目、密苏里大学圣路易斯市分校。路易斯（UMSL）行为神经科学博士课程，以及密苏里科技大学（MS&T）生物科学研究生课程。MU还与林肯大学建立了长期合作伙伴关系，林肯大学将为学生提供多元化和包容性。BETA利用全州UM系统的商业化和教育专业知识创建一个网络，招募和指导各种各样的学员，并为他们提供生物医学创新和沟通技巧，使他们成为致力于改善老龄化人口健康和福祉的科学工作队伍的高效成员。

The proportion of the US population of ≥65 years of age is expected to reach 22% by 2050. Healthcare innovations have played a crucial role in improving the health and well-being of the elderly population. Nevertheless, a major gap persists between academia and industry that must be bridged to drive innovation and commercialization of new drugs, devices, and technologies to combat age-related disorders, including Alzheimer’s disease (AD) and Alzheimer’s Disease related dementia (ADRD). Graduate students and post-doctoral trainees pursuing advanced training in age-related diseases constitute a vital work force capable of filling this gap; however, current training programs do not provide the business and communication skills needed to empower these trainees to fill this void. The overarching objective of the application is to grow the scientific work force promoting healthy aging through the creation of the Biomedical Entrepreneurship Training for Aging (BETA) program. MU is ideally suited to serve as the hub of an educational program focusing on graduate students and postdoctoral fellows pursuing careers in aging-related disciplines, as it co-localizes on one campus a school of medicine, college of engineering, school of health professions, college of nursing, school of journalism, and the comprehensive UM Health System. MU has outstanding programs that support entrepreneurial education, including the Life Science Innovation & Entrepreneurship Graduate Program, the Midwest Biomedical Accelerator Consortium, an NIH-funded Research Evaluation and Commercialization Hub (REACH), a Coulter Biomedical Accelerator, and the MU Life Science Business Incubator. The UM System, with >70,000 students and hundreds of graduate programs, provides a robust source of BETA trainees, including the MU Interdisciplinary Neuroscience Graduate Training Program, University of Missouri-Kansas City (UMKC) Doctoral Program in Applied Cognitive &Brain Sciences, University of Missouri-St. Louis (UMSL) Behavioral Neuroscience PhD program, and the Missouri S&T (MS&T) Graduate Program in Biological Sciences. MU also has a long-standing partnership with Lincoln University, an HBU that will source students to enable diversity and inclusion. BETA leverages the commercialization and educational expertise of the statewide UM System to create a network that recruits and mentors a diverse array of trainees and provides them with the biomedical innovation and communication skills needed to become highly productive members of the scientific work force devoted to improving the health and wellbeing of the aging population.